135 related articles for article (PubMed ID: 35180720)
1. The Rise and Fall of Bone Morphogenetic Protein 2 Throughout the United States.
Beschloss AM; DiCindio CM; Lombardi JS; Shillingford JN; Laratta JL; Holderread B; Louie P; Pugely AJ; Sardar Z; Khalsa AS; Arlet VM; Saifi C
Clin Spine Surg; 2022 Jul; 35(6):264-269. PubMed ID: 35180720
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011.
Singh K; Nandyala SV; Marquez-Lara A; Fineberg SJ
Spine (Phila Pa 1976); 2014 Mar; 39(6):491-6. PubMed ID: 24365905
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?
Guzman JZ; Merrill RK; Kim JS; Overley SC; Dowdell JE; Somani S; Hecht AC; Cho SK; Qureshi SA
Spine J; 2017 Sep; 17(9):1247-1254. PubMed ID: 28456674
[TBL] [Abstract][Full Text] [Related]
4. Impact of bone morphogenetic proteins on frequency of revision surgery, use of autograft bone, and total hospital charges in surgery for lumbar degenerative disease: review of the Nationwide Inpatient Sample from 2002 to 2008.
Dagostino PR; Whitmore RG; Smith GA; Maltenfort MG; Ratliff JK
Spine J; 2014 Jan; 14(1):20-30. PubMed ID: 23218827
[TBL] [Abstract][Full Text] [Related]
5. Off-label use of bone morphogenetic proteins in the United States using administrative data.
Ong KL; Villarraga ML; Lau E; Carreon LY; Kurtz SM; Glassman SD
Spine (Phila Pa 1976); 2010 Sep; 35(19):1794-800. PubMed ID: 20700081
[TBL] [Abstract][Full Text] [Related]
6. Utilization Trends of Recombinant Human Bone Morphogenetic Protein in the United States.
Kerezoudis P; Alvi MA; Freedman BA; Nassr A; Bydon M
Spine (Phila Pa 1976); 2021 Jul; 46(13):874-881. PubMed ID: 33395021
[TBL] [Abstract][Full Text] [Related]
7. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
[TBL] [Abstract][Full Text] [Related]
8. The use of bone morphogenetic protein in thoracolumbar spine procedures: analysis of the MarketScan longitudinal database.
Veeravagu A; Cole TS; Jiang B; Ratliff JK; Gidwani RA
Spine J; 2014 Dec; 14(12):2929-37. PubMed ID: 24842396
[TBL] [Abstract][Full Text] [Related]
9. Utilization trends and outcomes of computer-assisted navigation in spine fusion in the United States.
Kelley BV; Hsiue PP; Upfill-Brown AM; Chen CJ; Villalpando C; Lord EL; Shamie AN; Stavrakis AI; Park DY
Spine J; 2021 Aug; 21(8):1246-1255. PubMed ID: 33794362
[TBL] [Abstract][Full Text] [Related]
10. Current trends in demographics, practice, and in-hospital outcomes in cervical spine surgery: a national database analysis between 2002 and 2011.
Marquez-Lara A; Nandyala SV; Fineberg SJ; Singh K
Spine (Phila Pa 1976); 2014 Mar; 39(6):476-81. PubMed ID: 24365907
[TBL] [Abstract][Full Text] [Related]
11. Nationwide practice patterns in the use of recombinant human bone morphogenetic protein-2 in pediatric spine surgery as a function of patient-, hospital-, and procedure-related factors.
Lam SK; Sayama C; Harris DA; Briceño V; Luerssen TG; Jea A
J Neurosurg Pediatr; 2014 Nov; 14(5):476-85. PubMed ID: 25171721
[TBL] [Abstract][Full Text] [Related]
12. Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.
Hofstetter CP; Hofer AS; Levi AD
J Neurosurg Spine; 2016 Mar; 24(3):457-75. PubMed ID: 26613283
[TBL] [Abstract][Full Text] [Related]
13. Hospital outcomes and complications of anterior and posterior cervical fusion with bone morphogenetic protein.
Fineberg SJ; Ahmadinia K; Oglesby M; Patel AA; Singh K
Spine (Phila Pa 1976); 2013 Jul; 38(15):1304-9. PubMed ID: 23462577
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-associated complications in pediatric spinal fusion in the early postoperative period: an analysis of 4658 patients and review of the literature.
Rocque BG; Kelly MP; Miller JH; Li Y; Anderson PA
J Neurosurg Pediatr; 2014 Dec; 14(6):635-43. PubMed ID: 25303159
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures.
Cahill KS; Chi JH; Day A; Claus EB
JAMA; 2009 Jul; 302(1):58-66. PubMed ID: 19567440
[TBL] [Abstract][Full Text] [Related]
16. Use of Bone Morphogenetic Protein-2 in Vertebral Column Tumor Surgery: A National Investigation.
De la Garza Ramos R; Nakhla J; Echt M; Gelfand Y; Altschul DJ; Cho W; Kinon MD; Yassari R
World Neurosurg; 2018 Sep; 117():e17-e21. PubMed ID: 29733987
[TBL] [Abstract][Full Text] [Related]
17. The Use of Bone Morphogenetic Protein 2 (BMP-2) in Spine Surgery Is It Valuable?
Fernandez L; Petrizzo A
Bull Hosp Jt Dis (2013); 2023 Mar; 81(1):40-45. PubMed ID: 36821734
[TBL] [Abstract][Full Text] [Related]
18. Spinal fusion for pediatric neuromuscular scoliosis: national trends, complications, and in-hospital outcomes.
Rumalla K; Yarbrough CK; Pugely AJ; Koester L; Dorward IG
J Neurosurg Spine; 2016 Oct; 25(4):500-508. PubMed ID: 27203810
[TBL] [Abstract][Full Text] [Related]
19. Trends, payments, and costs associated with BMP use in Medicare beneficiaries undergoing spinal fusion.
Wadhwa H; Wu JY; Malacon K; Ames CP; Ratliff JK; Zygourakis CC
Spine J; 2023 Jun; 23(6):816-823. PubMed ID: 36709918
[TBL] [Abstract][Full Text] [Related]
20. RhBMP-2 is superior to iliac crest bone graft for long fusions to the sacrum in adult spinal deformity: 4- to 14-year follow-up.
Kim HJ; Buchowski JM; Zebala LP; Dickson DD; Koester L; Bridwell KH
Spine (Phila Pa 1976); 2013 Jun; 38(14):1209-15. PubMed ID: 23392417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
